| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Seagen Inc (NASDAQ: SGEN)
SGEN Technical Analysis
5
| As on 13th Dec 2023 SGEN STOCK Price closed @ 228.74 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 160.14 & Strong Buy for SHORT-TERM with Stoploss of 168.30 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SGENSTOCK Price
| Open | 228.93 | Change | Price | % |
| High | 228.96 | 1 Day | -0.16 | -0.07 |
| Low | 228.74 | 1 Week | 15.61 | 7.32 |
| Close | 228.74 | 1 Month | 15.93 | 7.49 |
| Volume | 20080000 | 1 Year | 51.80 | 29.28 |
| 52 Week High 221.60 | 52 Week Low 117.37 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| LMDX | 0.02 | 0.00% |
| YGMZ | 0.02 | -66.67% |
| AKTS | 0.04 | 0.00% |
| LILM | 0.05 | 0.00% |
| PONO | 1.72 | 2.38% |
| TELL | 1.00 | 0.00% |
| TPIC | 0.13 | -45.83% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SGEN Daily Charts |
SGEN Intraday Charts |
Whats New @ Bazaartrend |
SGEN Free Analysis |
|
|
SGEN Important Levels Intraday
| RESISTANCE | 229.16 |
| RESISTANCE | 229.03 |
| RESISTANCE | 228.94 |
| RESISTANCE | 228.86 |
| SUPPORT | 228.62 |
| SUPPORT | 228.54 |
| SUPPORT | 228.45 |
| SUPPORT | 228.32 |
SGEN Forecast December 2025
| 4th UP Forecast | 293.62 |
| 3rd UP Forecast | 272.81 |
| 2nd UP Forecast | 259.95 |
| 1st UP Forecast | 247.09 |
| 1st DOWN Forecast | 210.39 |
| 2nd DOWN Forecast | 197.53 |
| 3rd DOWN Forecast | 184.67 |
| 4th DOWN Forecast | 163.86 |
SGEN Weekly Forecast
| 4th UP Forecast | 252.15 |
| 3rd UP Forecast | 244.64 |
| 2nd UP Forecast | 240.00 |
| 1st UP Forecast | 235.36 |
| 1st DOWN Forecast | 222.12 |
| 2nd DOWN Forecast | 217.48 |
| 3rd DOWN Forecast | 212.84 |
| 4th DOWN Forecast | 205.33 |
SGEN Forecast2025
| 4th UP Forecast | 446.26 |
| 3rd UP Forecast | 376.5 |
| 2nd UP Forecast | 333.38 |
| 1st UP Forecast | 290.26 |
| 1st DOWN Forecast | 167.22 |
| 2nd DOWN Forecast | 124.1 |
| 3rd DOWN Forecast | 80.98 |
| 4th DOWN Forecast | 11.22 |
Seagen Inc ( NASDAQ USA Symbol : SGEN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SGEN Business Profile
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of metastatic urothelial cancers; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops Tisotumab Vedotin for metastatic cervical cancer and other solid tumors; ladiratuzumab vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and SpringWorks Therapeutics, Inc. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington. Address: 21823 30th Drive SE, Bothell, WA, United States, 98021
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service